血管生成
伤口愈合
肉芽组织
脐静脉
炎症
细胞外小泡
细胞生物学
细胞外基质
化学
细胞外
医学
伤口闭合
新生血管
糖尿病
人体皮肤
药理学
纤维蛋白
癌症研究
免疫学
细菌
皮肤修复
组织重塑
人脐静脉内皮细胞
胞外囊泡
慢性伤口
再生(生物学)
作者
Yuting Li,Zelin Zheng,Xiangxiang Kong,Yirong Wang,Zhinan Liu,Wen Wang,Honggang Hu,Feng Xu,Yejiao Shi
出处
期刊:Nano Research
[Springer Science+Business Media]
日期:2025-09-23
卷期号:18 (11): 94908083-94908083
被引量:6
标识
DOI:10.26599/nr.2025.94908083
摘要
Diabetic wounds are serious complications of diabetes. They are hard to heal due to the persistently hyperglycemic and hypoxemic wound microenvironment, disturbing the angiogenesis and compromising the re-epithelialization. With the highlight of gut-skin axis that is mediated by gut microbiota and their metabolites in regulating skin hemostasis, bacterial extracellular vesicles (BEVs) secreted by probiotics are being gradually exploited as the next generation of therapeutics for diabetic wound healing. Despite their remarkable healing efficacies, the underlying molecular mechanisms remain ambiguous. Herein, BEVs derived from Lactobacillus reuteri (LR-BEVs) were first isolated and sequenced. With the miR-21a-5p being identified as the primary inherent component, the LR-BEVs were subsequently demonstrated to be capable of delivering it into both endothelial and epidermal cells. Consequently, the proliferation, migration, and angiogenesis of human umbilical vein endothelial cells (HUVEC), as well as the proliferation and migration of human skin keratinocytes (HaCaT) were found to be promoted via the miR-21a-5p activated PI3K/AKT signaling pathway. In diabetic mice with full-thickness wound, the vascularized granulation tissue formation and re-epithelialization were expedited, while the inflammation was mitigated with the subcutaneous LR-BEVs treatment for 14 days. Timely diabetic wound closure was achieved without any obvious toxicity. These results envisioned the great potential of LR-BEVs as an alternative therapeutic modality for the effective and safe management of diabetic wounds.
科研通智能强力驱动
Strongly Powered by AbleSci AI